During a time of uncertainty where the SEC continues to issue mixed signals regarding the IFRS roadmap, industry leaders are left to implement a more efficient transition to new reporting and accounting standards. Solid decisions must be made in order to determine how much time and money should be spent on new accounting measures.
The Pharma Financial Forum 2009 is a premier event designed to provide accounting, reporting, and corporate governance executives with novel strategies for operating in the rapidly evolving drug manufacturing industry, and an outline for making a smooth transition to IFRS standards. At this year’s conference, you will hear case studies from accounting and regulatory leaders who provide an unparalleled combination of current strategies that will enable you to resourcefully position your accounting operations.
Be sure to visit our website for more information and complete program details.
Don’t miss out on this opportunity to stay ahead of the game. Join us today and walk away with an action plan for 2010.
Thursday, July 9, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment